Astrazeneca Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spite further political pushback ahead of the grilling by u. K. Lawmakers. And voting in indias mammoth fiveweek collection ends today with the first exit polls due in just a few hours. This kicks an alltime high in anticipation of those results. Youre watching Worldwide Exchange bringing you Business News from around the globe. Hello and welcome to the first Worldwide Exchange of the week. I bet you are happy. Absolutely overjoyed. What did they do . Well done, brilliant. Its okay. I feel proud. And im glad to be back. You have been on your travels. I have. Its good to be back. Yeah. Plenty t...

Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing early treatment for effective management. AstraZeneca's admission follows reports of TTS linked to adenovirus vector vaccines.